Attached files
file | filename |
---|---|
10-K - Guardion Health Sciences, Inc. | form10-k.htm |
EX-31.2 - Guardion Health Sciences, Inc. | ex31-2.htm |
EX-31.1 - Guardion Health Sciences, Inc. | ex31-1.htm |
EX-23.1 - Guardion Health Sciences, Inc. | ex23-1.htm |
EX-21.1 - Guardion Health Sciences, Inc. | ex21-1.htm |
EX-4.1 - Guardion Health Sciences, Inc. | ex4-1.htm |
EXHIBIT 32.1
CERTIFICATIONS PURSUANT TO
18 U.S.C. SECTION 1350,
AS ENACTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Guardion Health Sciences, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of Bret Scholtes, Chief Executive Officer of the Company, and Andrew Schmidt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as enacted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and | |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
March 26, 2021 | /s/ Bret Scholtes |
Bret Scholtes | |
Chief Executive Officer | |
(Principal Executive Officer) | |
March 26, 2021 | /s/ Andrew Schmidt |
Andrew Schmidt | |
Chief Financial Officer | |
(Principal Financial and Principal Accounting Officer) |